LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
From Silicon to Snowflakes Nov. 21Our Logo
Analyst recommendations: Ulta Beauty, Walmart, Nvidia, Snowflake, Target... Nov. 21Our Logo
Doximity Business Seeing 'Renewed Momentum,' Morgan Stanley Says in Upgrade Nov. 14 MT
Market pulse quickens with CPI and PPI beat Nov. 14Our Logo
Morgan Stanley Upgrades Doximity to Equalweight From Underweight, Boosts Price Target to $53 From $33 Nov. 14 MT
Analyst recommendations: Doximity, Cisco Systems, Hilton Worldwide, Nvidia, Spotify... Nov. 14Our Logo
Canaccord Genuity Downgrades Doximity to Hold From Buy, Adjusts Price Target to $60 From $40 Nov. 13 MT
Analyst recommendations: Spotify, Starbucks, Tesla, Block, Coinbase... Nov. 13Our Logo
Sector Update: Tech Stocks Mixed Late Afternoon Nov. 08 MT
Doximity Shares Soar After Analyst Upgrades, Fiscal Q2 Beat Nov. 08 MT
Top Premarket Gainers Nov. 08 MT
KeyBanc Upgrades Doximity to Overweight From Sector Weight, $70 Price Target Nov. 08 MT
Wells Fargo Upgrades Doximity to Equal Weight, $41 Price Target Nov. 08 MT
Profit-Taking Limits Wall Street Pre-Bell; Asian Mixed, Europe Off Nov. 08 MT
Doximity Shares Soar After Hours as Fiscal 2025 Adjusted EBITDA Guidance Lifted to $274 Million-$279 Million Nov. 07 MT
Doximity Shares Up 38% Late Hours After CEO Says 'Record' Use of Clinical Workflow Tools in Fiscal Q2 Nov. 07 MT
Doximity Fiscal Q2 Non-GAAP EPS, Revenue Surge; Full-Year Sales Outlook Lifted -- Shares Up After Hours Nov. 07 MT
Doximity, Inc. Revises Earnings Guidance for the Fiscal Year 2025 Nov. 07 CI
Doximity, Inc., Q2 2025 Earnings Call, Nov 07, 2024 Nov. 07
Doximity Guides For Q3 Revenue of $152-$153 Million, vs CIQ Analyst Consensus of $141 Million Nov. 07 MT
Earnings Flash (DOCS) DOXIMITY Reports Q2 Revenue $136.8M Nov. 07 MT
Earnings Flash (DOCS) DOXIMITY Posts Q2 EPS $0.30 Nov. 07 MT
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on May 16, 2024. Nov. 07 CI
Doximity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 Nov. 07 CI
Doximity, Inc. Reports Impairment of Long-Lived Assets for the Second Quarter Ended September 30, 2024 Nov. 07 CI
Chart Doximity, Inc.
DOCS: Dynamic Chart
Logo Doximity, Inc.
Doximity, Inc. provides a digital platform for the United States medical professionals. It provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, stay up to date with the latest medical news and research and manage their careers. It offers Marketing, Hiring, and Productivity Solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and certain other healthcare companies. Its Marketing Solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its Hiring Solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its Productivity Solutions include its telehealth, on-call scheduling, and artificial intelligence (AI)-supported medical correspondence tools and are designed to help clinicians streamline their clinical workflow.
Employees
827
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart DOXIMITY-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
53.41USD
Average target price
55.27USD
Spread / Average Target
+3.48%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. News Doximity, Inc.
  5. Doximity Shares Soar After Analyst Upgrades, Fiscal Q2 Beat
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW